Health Technology Assessment of the Health Economics Working Group under the Subcommittee for the Development of the National List of Essential Medicines between 2016 and 2018
Keywords:
National List of Essential Medicines, Health Economics Working Group, health technology assessment, health economic evaluationAbstract
The National List of Essential Medicines (NLEM) in Thailand was first developed in 1972 and has been revised continuously. In 2008, health economic evaluation and budget impact analysis became a part of the development process of the NLEM, especially for high-cost or high-budget medicines to control healthcare expenses and promote the effectiveness of healthcare services. The Health Economics Working Group (HEWG) under the Subcommittee for the Development of the NLEM has served an important role in health technology assessment (HTA) to the Subcommittee. No studies had ever attempted to review the processes and outputs of the HEWG’s authority. Therefore, this study aimed to investigate HTA processes and outputs of the HEWG between 2016 and 2018. The study design was descriptive research employing two main approaches, namely document reviews and participant observations as secretariat members of the HEWG. Data analysis comprised descriptive statistics and content analysis. Results were reported in two parts consisting of the HEWG’s work processes and research outputs. The results on work processes indicated that the HEWG’s operational procedures consisted of three main activities: the selection of research team, the managing of research compliant to HTA guidelines, and the quality review and appraisal of research output. As for research outputs, 30 research topics were proposed between 2016 and 2018, with 17 topics (56%) being completed and submitted to the Coordination and Consolidation Working Group for further action. Additionally, the composition of the HEWG and research teams came from multiple sectors of the health systems, leading to inclusive participation and a high degree of transparency. The research process under the HEWG had clear procedures and timelines to support the development of the NLEM in a timely manner, and included a rigorous appraisal of research quality. However, the HEWG should further develop and update their operational procedures to overcome certain problems and obstacles such as the lack of human resources and an inefficient management system, and to prepare for new future challenges.
References
World Health Organization. Universal health coverage (UHC) [internet]. 2019 [updated 24 January 2019; cited 2020 Mar 15]. Available from: https://www.who.int/news-room/fact-sheets/detail/universal-health-coverage-(uhc).
Viriyathorn. S, Wanwong. Y, Rueangsom. P, Wangbunjongkun. W, Sinam. P. Thailand UHC and overview of the universal coverage scheme of the national health security office [internet]. National Health Security Office; 2019 [cited 2020 Mar 15]. Available from: http://eng.nhso.go.th/assets/portals/1/files/01%20UCS%20OVERVIEW%20of%20UHC%20and%20UCS.pdf.
Ottersen. T, Norheim. OF, Chitah. BM, Cookson. R, Daniels. N, Defaye. FB, et al. Making fair choices on the path to universal health coverage. Geneva: World Health Organization; 2014.
Medicines Regulation Division, Food and Drug Administration, Ministry of Public Health. Situation on drug security and health expenditure 2016 [cited 2020 Mar 15]. Available from: http://www.fda.moph.go.th/sites/drug/SitePages/National_Policy_Download.aspx?IDdata=2. (in Thai)
Teerawattananon Y, Tantivess S, Yothasamut J, Kingkaew P, Chaisiri K. Historical development of health technology assessment in Thailand. International Journal of Technology Assessment in Health Care 2009;25 Suppl 1:241-52.
National Drug System Development Committee. The 2013 National List of Essential Medicines [updated 2013 Sep 30; cited 2020 Mar 15]. Available from: http://www.ratchakitcha.soc.go.th/DATA/PDF/2556/E/126/11.PDF. (in Thai)
Chaikledkaew U, Teerawattananon Y, editors. Guidelines for health technology assessment in Thailand. 2nd ed. Nonthaburi: Health Intervention and Technology Assessment Program; 2014. (in Thai)
Chaikledkaew U, Teerawattananon Y, Khongpittayachai S, Suksombiin N, editors. Guidelines for health technology assessment in Thailand. Nonthaburi: Health Intervention and Technology Assessment Program; 2009. (in Thai)
Leelahavarong P, Doungthipsirikul S, Kumluang S, Poonchai A, Kittiratchakool N, Chinnacom D, et al. Health technology assessment in Thailand: institutionalization and contribution to healthcare decision making: review of literature. International Journal of Technology Assessment in Health Care. 2019;35(6):467-73.
Perez R, Chaikledkaew U, Youngkong S, Tantivess S, Teerawattananon Y. Health technology assessment process guidelines. Nonthaburi: Health Intervention and Technology Assessment Program (HITAP); 2012.
Jerry Chung-Lin Yang, editor. Patient involvement in HTA in Taiwan. The ISPOR 22nd Annual International Meeting; 2017 May 20-24; Boston, MA, USA: SPOR’s Global Networks groups.
Chang C-M, editor. Patient involvement in HTA process in Taiwan. ISPOR Asia Pacific 2018; 2018 Sep 8-11; Tokyo, Japan: SPOR’s Global Networks groups.
Ministry of Health and Welfare. National Health Insurance Act: The Working Group of The R.O.C Laws & Regulations Database, Ministry of Justice [internet]. 2020 [updated Jan 15, 2020; cited 2020 Jun 1]. Available from: https://law.moj.gov.tw/Eng/LawClass/LawAll.aspx?pcode=L0060001.
Department of Health Australian Government. Pharmaceutical Benefits Scheme (PBS) [internet]. 2020 [updated 2020 Jun 2; cited 2020 Jun 15]. Available from: http://www.pbs.gov.au/pbs/home.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Journal of Health Systems Research is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license, unless otherwise stated.
